Advanced Biomed vs Alpha Compute
ADVB and ALP side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADVB and ALP compare
Advanced Biomed scores higher on the StockData Score (8 against 4 for Alpha Compute), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADVB | ALP |
|---|---|---|
| Size and price | ||
| Market cap | $4.2M | – |
| Share price | $2.53 | $3.17 |
| Change, 1 year | −72.0% | −98.4% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | 0.81 | 1.27 |
| Employees | 12 | 2 |
| StockData Score | ||
| Total score | 8 (better) | 4 |
| Valuation score | 2 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 0.4× | – |
| P/B | 0.4× | – |
| Profitability | ||
| Operating margin | – | −23810% |
| Net margin | – | −39821% |
| FCF margin | – | −22256% |
| Return on equity | 85.0% (better) | −1087% |
| Return on invested capital | – | −737% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 8.09 (better) | 0.31 |
| Altman Z-score | 1.13 | – |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | – | 0.22% |
| Held by insiders | 0.00% | 4.5% |
| Insider net buying, 12 months | – | $313K |
| Short interest, % of float | 0.68% | 0.79% |
Go deeper
- ADVB stock overview
- ADVB income statement
- ADVB valuation and score
- ALP stock overview
- ALP income statement
- ALP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.